Cryotherapy applies targeted cold to the skin tag. The physician checks whether cold spread stays away from the lashes and tear duct opening.
Liquid nitrogen creates controlled destruction of the small targeted tissue, which then gradually dries.
Cryotherapy is mainly discussed when the skin tag is small, well-defined, and far enough from the eyelid margin.
Near the lashes, tear duct opening, or on certain skin types, another approach may be more cautious.
Cryotherapy works because cold spreads through treated tissue. On an eyelid, that spread can affect a wider area than the lesion.
The physician also checks skin tone and the risk of a lighter or darker mark. If the safety margin is too small, another technique may be discussed.
Cryotherapy mainly targets small superficial lesions that are well-defined and located at a safe distance from the eye.
Small superficial skin tag, well defined and away from the eyelid margin.
Benign appearance confirmed, without bleeding or rapid change.
Temporary crusting, redness, and possible pigment mark understood before treatment.
Safe distance from the lashes, tear duct opening, and eye surface.
Cold treatment is not always the best option near the eye, especially when location, skin tone, or lesion appearance increases risk.
Lesion against the lashes, the free margin, or tear duct opening.
Darker skin with strong concern about a lighter spot.
Broad base, thick lesion, or poorly defined borders.
Bleeding, crusting, rapid change, or lash loss.
Diagnostic doubt or need to send a sample for analysis.
The physician first confirms whether cold treatment can be discussed. If the margin is sufficient, the eye is protected and cold is applied only to the lesion.
She checks distance from the lashes, tear duct opening, and eyelid margin.
If cryotherapy is discussed, the eye is protected and cold stays focused on the skin tag.
The physician explains expected redness, possible crusting, and which signs should be reported.
THE CARE EXPERIENCE
Family Physician Trained at the Université de Montréal and a current member in good standing of the Collège des médecins du Québec (CMQ), Dr. Karen Dzolang serves as the medical director of the CARE network. For eyelid lesions like xanthelasma, she helps frame the assessment, possible indications, limits of removal, and situations where another medical opinion might be preferable.
